Heron Patrick J

CIK 0001365617

Director10% Owner

Filings

Latest Jan 27, 2026

Issuers covered

Showing

39 of 39

Page 1

Track record

31 of 34 open-market trades scored (91% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	31	32%	-1.5%	-3.6%	+18.4%	-15.1%
90 days	31	87%	+10.5%	+8.4%	+76.5%	-25.4%
180 days	30	80%	+61.4%	+70.2%	+274.1%	-59.1%
365 days	26	96%	+77.8%	+75.7%	+249.4%	-55.0%

Issuers

Companies where Heron Patrick J has filed

Ticker	Issuer	Filings	Last filed
MIRM	Mirum Pharmaceuticals, Inc.	15	Jan 27, 2026
ARQT	Arcutis Biotherapeutics, Inc.	12	Jun 17, 2025
HLVX	Hillevax, Inc.	7	Sep 17, 2025
MBX	Mbx Biosciences, Inc.	4	Sep 30, 2025
ALPN	Alpine Immune Sciences, Inc.	1	Feb 15, 2022

All filings

39 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Jan 27, 2026	MIRMMirum Pharmaceuticals, Inc.	PPurchase	131,425	$68.48	$8,999,984
Sep 30, 2025	MBXMbx Biosciences, Inc.	PPurchase	666,666	$18.00	$11,999,988
Sep 17, 2025	HLVXHillevax, Inc.	UTender	8,535,337	$1.95	$16,643,907
Jun 25, 2025	HLVXHillevax, Inc.	AGrant	17,199	$0.00	$0
Jun 17, 2025	ARQTArcutis Biotherapeutics, Inc.	PPurchase	2,646	$13.0803	$34,610
Jun 16, 2025	ARQTArcutis Biotherapeutics, Inc.	AGrant	7,609	$0.00	$0
Jun 6, 2025	MBXMbx Biosciences, Inc.	Holdings only	-	-	-
Jun 6, 2025	ARQTArcutis Biotherapeutics, Inc.	PPurchase	1,890	$13.3214	$25,177
Jun 2, 2025	MIRMMirum Pharmaceuticals, Inc.	MExercise	5,703	-	-
May 23, 2025	ARQTArcutis Biotherapeutics, Inc.	PPurchase	2,520	$13.66	$34,423
May 19, 2025	ARQTArcutis Biotherapeutics, Inc.	PPurchase	2,520	$13.6178	$34,317
May 15, 2025	ARQTArcutis Biotherapeutics, Inc.	PPurchase	6,300	$13.7605	$86,691
May 13, 2025	ARQTArcutis Biotherapeutics, Inc.	PPurchase	6,300	$13.6018	$85,691
Apr 30, 2025	HLVXHillevax, Inc.	Holdings only	-	-	-
Mar 18, 2025	MIRMMirum Pharmaceuticals, Inc.	PPurchase	528	$44.1125	$23,291
Mar 12, 2025	MIRMMirum Pharmaceuticals, Inc.	PPurchase	963	$43.7748	$42,155
Mar 10, 2025	MIRMMirum Pharmaceuticals, Inc.	PPurchase	1,335	$43.8928	$58,597
Mar 6, 2025	MIRMMirum Pharmaceuticals, Inc.	PPurchase	1,279	$45.5486	$58,257
Sep 20, 2024	MIRMMirum Pharmaceuticals, Inc.	PPurchase	115	$37.40	$4,301
Sep 17, 2024	MBXMbx Biosciences, Inc.	PPurchase	625,000	$16.00	$10,000,000
Sep 13, 2024	MBXMbx Biosciences, Inc.	Holdings only	-	-	-
Sep 10, 2024	MIRMMirum Pharmaceuticals, Inc.	PPurchase	230	$41.5783	$9,563
Jun 18, 2024	ARQTArcutis Biotherapeutics, Inc.	AGrant	10,139	$0.00	$0
Jun 7, 2024	MIRMMirum Pharmaceuticals, Inc.	Holdings only	-	-	-
May 31, 2024	HLVXHillevax, Inc.A	Holdings only	-	-	-
Apr 8, 2024	HLVXHillevax, Inc.	PPurchase	8,850	$14.50	$128,325
Mar 6, 2024	ARQTArcutis Biotherapeutics, Inc.	PPurchase	21,052	$9.50	$199,994
Nov 14, 2023	MIRMMirum Pharmaceuticals, Inc.	PPurchase	2,910	$28.30	$82,353
Oct 26, 2023	ARQTArcutis Biotherapeutics, Inc.	PPurchase	80,000	$2.50	$200,000
Sep 15, 2023	MIRMMirum Pharmaceuticals, Inc.	PPurchase	2,625	$31.019	$81,425
Sep 13, 2023	MIRMMirum Pharmaceuticals, Inc.	PPurchase	4,687	$30.3024	$142,027
Sep 5, 2023	MIRMMirum Pharmaceuticals, Inc.	PPurchase	147,991	$26.25	$3,884,764
Jun 14, 2023	MIRMMirum Pharmaceuticals, Inc.	Holdings only	-	-	-
Jun 9, 2023	HLVXHillevax, Inc.	Holdings only	-	-	-
Jun 2, 2023	ARQTArcutis Biotherapeutics, Inc.	AGrant	4,375	$0.00	$0
Jun 6, 2022	MIRMMirum Pharmaceuticals, Inc.	Holdings only	-	-	-
Jun 3, 2022	ARQTArcutis Biotherapeutics, Inc.	AGrant	4,312	$0.00	$0
May 3, 2022	HLVXHillevax, Inc.	CConversion	2,736,234	$13.60	$37,212,782
Feb 15, 2022	ALPNAlpine Immune Sciences, Inc.	PPurchase	112,665	$7.1006	$799,989

Showing 1-39 of 39

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value